Maetzel A, Ferraz MB, Bombadier C: The cost-effectiveness of
misoprostol in preventing serious gastrointestinal events asso-
ciated with the use of nonsteroidal antiinflammatory drugs.
Arthritis and Rheum41(1):16–25, 1998.
Martineau L, Horan MA, Rothwell NJ, et al: Salbutamol a Beta
2 adrenoceptor agonis increases skeletal muscle strength in
young men. Clin Sci83:615–622, 1992.
Moore RA, Tramer MR, Caroll D, et al: Quantitative systematic
review of topically applied non-steroidal anti-inflammatory
drugs. Br Med J316(7128):333–338, 1998.
Morreale P, Manopulo R, Galati M, et al: Comparison of the anti-
inflammatory efficacy of chondroitin sulfate and diclofenac
sodium in patients with knee osteoarthritis. J Rheum23(8):
1385–1391, 1996.
Morris AC, Jacobs I, McLellan TM, et al: No ergogenic effect of
ginseng ingestion. Int J Sport Nutr6(3):263–271, 1996.
Mukherjee D: Risk of cardiovascular events associated with
selective COX-2 inhibitors. JAMA286(8):954–959, 2001.
National Collegiate Athletic Association: Sports Sciences.
Indianapolis, IN, 2003.
Ogilvie-Harris DJ, Gilbart M: Treatment modalities for soft
tissue injuries of the ankle: A critical review. Clin J Sports Med
5(3):175–186, 1995.
Pasman WJ, van Baak MA, Jeukendrup AE, et al: The effect of
different dosages of caffeine on endurance performance time.
Int J Sports Med16(4):225–130, 1995.
Prather ID, Brown DE, North P, et al: Clenbuterol: A substitute for
anabolic steroids? Med Sci Sports Exerc27(8):1118–1121, 1995.
Pritzalff CJ, Wideman L, Weltman JY, et al: Impact of acute exer-
cise intensity on pulsatile growth hormone release in men.
J Appl Physiol87(2):498–504, 1999.
Reid MB, Stokic DS, Koch SM, et al: N-acetylcysteine inhibits
muscle fatigue in humans. J Clin Invest94(6):2468–2474, 1994.
Sawka MN, Joyner MJ, Miles DS, et al: The use of blood doping
as an ergogenic aid, ACSM position stand. Med Sci Sports
Exerc28(3):i–viii, 1996.
Schardt D: Relieving arthritis, can supplements help? Nutr Action
Jan/Feb:3–6, 1998.
Schoenfeld P: An evidence-based approach to the gastrointestinal
safety profile of COX–2-selective anti-inflammatories.
Gastroenterol Clin North Am30(4):1027–1044, viii–ix, 2001.
Sidney KH, Lefcoe NM: The effects of ephedrine on the physio-
logical and psychological responses to submaximal and maxi-
mal exercise in man. Med Sci Sports9(2):95–99, 1977.
Simon LS, Smith TJ: NSAID mechanism of action, efficacy, and
relative safety. Managing Arthritis: A Postgraduate Medicine
Special Report March:17–22, 1998.
Singh A, Moses F, Deuster PA: Chronic multivitamin-mineral
supplementation does not enhance physical performance. Med
Sci Sports Exerc24(6):726–732, 1992.
Smith GM, Beecher HK: Amphetamine sulfate and athletic per-
formance. J Am Med Assoc 170:524–557, 1959.
Snider IP, Bazzarre TL, Murdoch SD, et al: Effects of coenzyme
athletic performance system as an ergogenic aid on endurance
performance to exhaustion. Int J Sports Nutr2(3):272–286,
1992.
Soja AM, Mortensen SA: Treatment of congestive heart failure
with coenzyme Q10 illuminated by meta-analysis of clinical
trials. Mol Aspects Med 18(Supp):S519–S568, 1997.
Stanley KL, Weaver JE: Pharmacologic management of pain and
inflammation in athletes. Clin Sports Med17(2):375–392, 1998.
Stricker PR: Sports pharmacology. Other ergogenic aids. Clin
Sports Med17(2):283–297, 1998.
Sturmi JE, Diorio DJ: Sports pharmacology. Anabolic agents.
Clin Sports Med 17(2):261–264, 1998.
Swain RA, Harsha DM, Baenziger J, et al: Do pseudoephedrine or
phenylpropanolamine improve maximum oxygen uptake and
time to exhaustion? Clin J Sports Med7(3):168–173, 1997.
U.S. Antidoping Agency: USADA Guide to Prohibited Classes
of Substances and Prohibited Methods of Doping.
http://www.usantidoping.org.
U.S. Department of Health and Human Services: FDA statement on
street drugs containing the botanical ephedrine. April 10, 1996.
Weight LM, Myburgh KH, Noakes TD: Vitamin and mineral sup-
plementation: Effect on running performance of trained ath-
letes. Am J Clin Nutr47(2):192–195, 1988.
Weight LM, Noakes TD, Labadarios D, et al: Vitamin and min-
eral status of trained athletes including the effects of supple-
mentation. Am J Clin Nutr47(2):186–191, 1988.
Weiler JM, Layton T, Hunt M: Asthma in United States Olympic
athletes who participated in the 1996 Summer Games.
J Allergy Clin Immunol 102(5):722–726, 1998.
Welle S, Jozefowicz R, Statt M: Failure of dehydroepiandros-
terone to influence energy and protein metabolism in humans.
J Clin Endocrinol Metab 71(5):1259–1264, 1990.
Williams MH: Nutrtional ergogenics in athletics. J Sports Sci
13:S63–S74, 1995.
Yamamoto DS: Cyclooxygenase-2: From arthritis treatment to
new indications for the prevention and treatment of cancer.
Clin J Oncol Nurs7(1):21–29, 2003.71 COMMON INJECTIONS IN
SPORTS MEDICINE: GENERAL
PRINCIPLES AND SPECIFIC
TECHNIQUES
Francis G O’Connor, MD, FACSMINTRODUCTION- Injections are a common intervention provided by
sports clinicians. Injections can be both diagnostic
and therapeutic. If delivered properly and with sound
indications, injections can be very rewarding for both
the patient and the provider. - This chapter details the indications, benefits, risks, and
technique for administering common injections in
sports medicine. These injections, while in most cases
simple to administer, should be done only after proper
training and appropriate supervision. Most injections
are simple to learn (see one, do one, teach one); judg-
ment on their use, however, takes time/effort to acquire.
426 SECTION 5 • PRINCIPLES OF REHABILITATION